Trademark Search  /  IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC

IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC

○ Dead · Cancelled

U.S. federal trademark · Serial No. 85595704 · Reg. No. 4485747

Mark
IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC
Status
Cancelled
Serial Number
85595704
Registration No.
4485747
Filing Date
April 12, 2012
Registration Date
February 18, 2014
Class(es)
Class 042

Owners

Bristol-Myers Squibb Company
03 · New York, NY, US
Bristol-Myers Squibb Company
03 · New York, NY, US
Bristol-Myers Squibb Company
03 · New York, NY, US

Goods & Services

Product research and development; conducting clinical trials relating to pharmaceutical preparations for human use

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.